Genetic Biomarkers in Aortopathy

• Angouras DC , BoudoulasKD, BoudoulasH. Bovine aortic arch: normal variant or a marker of aortopathy?Cardiology123(2), 113–115 (2012).
   PubMed Web of Science ®Google Scholar
• Danyi P , ElefteriadesJA, JovinIS. Medical therapy of thoracic aortic aneurysms. Trends Cardiovasc. Med.22(7), 180–184 (2012).
   PubMed Web of Science ®Google Scholar
• Elefteriades JA , FarkasEA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J. Am. Coll. Cardiol.55(9), 841–857 (2010).
   PubMed Web of Science ®Google Scholar
• Elefteriades JA . Biomarkers for diagnosis in thoracic aortic disease. Cardiol. Clin.28(2), 221–222 (2010).
   PubMed Web of Science ®Google Scholar
• Lindsay ME , DietzHC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature473(7347), 308–316 (2011).
   PubMed Web of Science ®Google Scholar
• Jain D , DietzHC, OswaldGL, MaleszewskiJJ, HalushkaMK. Causes and histopathology of ascending aortic disease in children and young adults. Cardiovasc. Pathol.20(1), 15–25 (2011).
   PubMed Web of Science ®Google Scholar
• Puranik R , ChowCK, DuflouJA, KilbornMJ, McGuireMA. Sudden death in the young. Heart Rhythm.2(12), 1277–1282 (2005).
   PubMed Web of Science ®Google Scholar
• Suzuki T , BossoneE, SawakiDet al. Biomarkers of aortic diseases. Am. Heart J. 165(1), 15–25 (2013).
   PubMed Web of Science ®Google Scholar
• El-Hamamsy I , YacoubMH. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat. Rev. Cardiol.6(12), 771–786 (2009).
   PubMed Web of Science ®Google Scholar
• Moltzer E , EssersJ, van EschJH, Roos-HesselinkJW, DanserAHJ. The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications. Pharmacol. Therapeut. 131(1), 50–60 (2011).
   PubMed Web of Science ®Google Scholar
• Holm TM , HabashiJP, DoyleJJet al. Noncanonical TGFβ signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332(6027), 358–361 (2011).
   PubMed Web of Science ®Google Scholar
• Brooke BS , HabashiJP, JudgeDP, PatelN, LoeysB, DietzHC 3rd. Angiotensin II blockade and aortic-root dilation in Marfan‘s syndrome. N. Engl. J. Med. 358(26), 2787–2795 (2008).
   PubMed Web of Science ®Google Scholar
• Elefteriades JA . Thoracic aortic aneurysm: reading the enemy‘s playbook. World. J. Surg.32(3), 366–374 (2008).
   PubMed Web of Science ®Google Scholar
• Moberg K , De NobeleS, DevosDet al. The Ghent Marfan Trial – a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers. Int. J. Cardiol. 157(3), 354–358 (2012).
   PubMed Web of Science ®Google Scholar
• Dietz HC , CuttingGR, PyeritzREet al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352, 337–339 (1991).
   PubMed Web of Science ®Google Scholar
• Faivre L , Collod-BeroudG, LoeysBLet al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am. J. Hum. Genet. 81(3), 454–466 (2007).
   PubMed Web of Science ®Google Scholar
• Braverman AC . Transforming growth factor-{beta}: a biomarker in Marfan syndrome?Circulation120(6), 464–466 (2009).
   PubMed Web of Science ®Google Scholar
• Chung BH , LamST, TongTMet al. Identification of novel FBN1 and TGFBR2 mutations in 65 probands with Marfan syndrome or Marfan-like phenotypes. Am. J. Med. Genet. A 149A(7), 1452–1459 (2009).
   PubMed Web of Science ®Google Scholar
• Hoffjan S . Genetic dissection of marfan syndrome and related connective tissue disorders: an update 2012. Mol. Syndromol.3(2), 47–58 (2012).
   PubMedGoogle Scholar
• Hiratzka LF , BakrisGL, BeckmanJAet al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American. Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J. Am. Coll. Cardiol. 55(14), e27–e129 (2010).
   PubMed Web of Science ®Google Scholar
• Kim L , DevereuxRB, BassonCT. Impact of genetic insights into mendelian disease on cardiovascular clinical practice. Circulation123(5), 544–550 (2011).
   PubMed Web of Science ®Google Scholar
• Barrett PM , TopolEJ. The fibrillin-1 gene: unlocking new therapeutic pathways in cardiovascular disease. Heart99(2), 83–90 (2013).
   PubMed Web of Science ®Google Scholar
• Trimarchi S , SangiorgiG, SangXet al. In search of blood tests for thoracic aortic diseases. Ann. Thorac. Surg. 90(5), 1735–1742 (2010).
   PubMed Web of Science ®Google Scholar
• Matt P , SchoenhoffF, HabashiJet al. Circulating transforming growth factor-beta in Marfan syndrome. Circulation 120(6), 526–532 (2009).
   PubMed Web of Science ®Google Scholar
• Suzuki T , TrimarchiS, SawakiDet al. Circulating transforming growth factor-beta levels in acute aortic dissection. J. Am. Coll. Cardiol. 58(7), 775–775 (2011).
   PubMed Web of Science ®Google Scholar
• Franken R , den HartogAW, de WaardVet al. Circulating transforming growth factor-beta as a prognostic biomarker in Marfan syndrome. Int. J. Cardiol. doi:10.1016/j.ijcard.2013.03.033 (2013) (Epub ahead of print).
   Web of Science ®Google Scholar
• Jones JA , IkonomidisJS. The pathogenesis of aortopathy in Marfan syndrome and related diseases. Curr. Cardiol. Rep.12(2), 99–107 (2010).
   PubMedGoogle Scholar
• Loeys BL , DietzHC, BravermanACet al. The revised Ghent nosology for the Marfan syndrome. J. Med. Genet. 47(7), 476–485 (2010).
   PubMed Web of Science ®Google Scholar
• Detaint D , AegerterP, TubachFet al. Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome. Arch. Cardiovasc. Dis. 103(5), 317–325 (2010).
   PubMed Web of Science ®Google Scholar
• Loeys BL , ChenJ, NeptuneERet al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37(3), 275–281 (2005).
   PubMed Web of Science ®Google Scholar
• Loeys BL , SchwarzeU, HolmTet al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N. Engl. J. Med. 355(8), 788–798 (2006).
   PubMed Web of Science ®Google Scholar
• Boileau C , GuoDC, HannaNet al. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat. Genet. 44(8), 916–921 (2012).
   PubMed Web of Science ®Google Scholar
• Lindsay ME , SchepersD, BolarNAet al. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat. Genet. 44(8), 922–927 (2012).
   PubMed Web of Science ®Google Scholar
• Kent KC , CrenshawML, GohDL, DietzHC. Genotype–phenotype correlation in patients with bicuspid aortic valve and aneurysm. J. Thorac. Cardiovasc. Surg.146(1), 158–165.e1 (2012).
   PubMed Web of Science ®Google Scholar
• Biner S , RafiqueAM, RayI, CukO, SiegelRJ, TolstrupK. Aortopathy is prevalent in relatives of bicuspid aortic valve patients. J. Am. Coll. Cardiol.53(24), 2288–2295 (2009).
   PubMed Web of Science ®Google Scholar
• Sievers HH , SieversHL. Aortopathy in bicuspid aortic valve disease – genes or hemodynamics? or Scylla and Charybdis?Eur. J. Cardiothorac. Surg.39(6), 803–804 (2011).
   PubMed Web of Science ®Google Scholar
• McKellar SH , TesterDJ, YagubyanM, MajumdarR, AckermanMJ, SundtTM3rd. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J. Thorac. Cardiovasc. Surg. 134(2), 290–296 (2007).
   PubMed Web of Science ®Google Scholar
• Della Corte A , BanconeC, QuartoCet al. Predictors of ascending aortic dilatation with bicuspid aortic valve: a wide spectrum of disease expression. Eur. J. Cardiothorac. Surg. 31(3), 397–404; discussion 404–405 (2007).
   PubMed Web of Science ®Google Scholar
• Forte A , Della CorteA, GrossiMet al. Early cell changes and TGFbeta pathway alterations in the aortopathy associated with bicuspid aortic valve stenosis. Clin. Sci. 124(2), 97–108 (2013).
   Web of Science ®Google Scholar
• Coucke PJ , WillaertA, WesselsMWet al. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. Nat. Genet. 38(4), 452–457 (2006).
   PubMed Web of Science ®Google Scholar
• Willaert A , KhatriS, CallewaertBLet al. GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGFβ signaling. Hum. Mol. Genet. 21(6), 1248–1259 (2012).
   PubMed Web of Science ®Google Scholar
• Regalado ES , GuoDC, VillamizarCet al. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ. Res. 109(6), 680–686 (2011).
   PubMed Web of Science ®Google Scholar
• van de Laar IM , van der LindeD, OeiEHet al. Phenotypic spectrum of the SMAD3-related aneurysms–osteoarthritis syndrome. J. Med. Genet. 49(1), 47–57 (2012).
   PubMed Web of Science ®Google Scholar
• van der Linde D , van de LaarIM, Bertoli-AvellaAMet al. Aggressive cardiovascular phenotype of aneurysms–osteoarthritis syndrome caused by pathogenic SMAD3 variants. J. Am. Coll. Cardiol. 60(5), 397–403 (2012).
   PubMed Web of Science ®Google Scholar
• Andrabi S , BekheirniaMR, Robbins-FurmanP, LewisRA, PriorTW, PotockiL. SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction. Am. J. Med. Genet. A155A(5), 1165–1169 (2011).
   PubMed Web of Science ®Google Scholar
• Teekakirikul P , MilewiczDM, MillerDTet al. Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations. Am. J. Med. Genet. A 161A(1), 185–191 (2013).
   PubMed Web of Science ®Google Scholar
• Lindor NM , GunawardenaSR, ThibodeauSN. Mutations of SMAD4 account for both LAPS and Myhre syndromes. Am. J. Med. Genet. A158A(6), 1520–1521 (2012).
   PubMed Web of Science ®Google Scholar
• Le Goff C , MahautC, AbhyankarAet al. Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat. Genet. 44(1), 85–88 (2012).
   Web of Science ®Google Scholar
• Doyle AJ , DoyleJJ, BesslingSLet al. Mutations in the TGF-β repressor SKI cause Shprintzen–Goldberg syndrome with aortic aneurysm. Nat. Genet. 44(11), 1249–1254 (2012).
   PubMed Web of Science ®Google Scholar
• Berk DR , BentleyDD, BaylissSJ, LindA, UrbanZ. Cutis laxa: a review. J. Am. Acad. Dermatol.66(5), 842.e1–17 (2012).
   PubMed Web of Science ®Google Scholar
• Dietz HC . TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J. Clin. Invest.120(2), 403–407 (2010).
   PubMed Web of Science ®Google Scholar
• Guo DC , PannuH, Tran-FaduluVet al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 39(12), 1488–1493 (2007).
   PubMed Web of Science ®Google Scholar
• Guo DC , PapkeCL, Tran-FaduluVet al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am. J. Hum. Genet. 84(5), 617–627 (2009).
   PubMed Web of Science ®Google Scholar
• Sodeck G , DomanovitsH, SchillingerMet al. Pre-operative N-terminal pro-brain natriuretic peptide predicts outcome in type A aortic dissection. J. Am. Coll. Cardiol. 51(11), 1092–1097 (2008).
   PubMed Web of Science ®Google Scholar
• Gutin LS , BakalovVK, RosingDR, AraiAE, GharibAM, BondyCA. N-terminal pro-brain natriuretic peptide levels and aortic diameters. Am. Heart J.164(3), 419–424 (2012).
   PubMed Web of Science ®Google Scholar
• Potocki L , BiW, Treadwell-DeeringDet al. Characterization of Potocki–Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am. J. Hum. Genet. 80(4), 633–649 (2007).
   PubMed Web of Science ®Google Scholar
• Jefferies JL , PignatelliRH, MartinezHRet al. Cardiovascular findings in duplication 17p11.2 syndrome. Genet. Med. 14(1), 90–94 (2012).
   PubMed Web of Science ®Google Scholar
• Ferner RE . Neuro-fibromatosis 1 and neuro-fibromatosis 2: a twenty first century perspective. Lancet Neurol.6(4), 340–351 (2007).
   PubMed Web of Science ®Google Scholar
• Lemaire SA , RussellL. Epidemiology of thoracic aortic dissection. Nat. Rev. Cardiol.8(2), 103–113 (2011).
   PubMed Web of Science ®Google Scholar
• Lemaire SA , McDonaldML, GuoDCet al. Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1. Nat. Genet. 43(10), 996–1000 (2011).
   PubMed Web of Science ®Google Scholar
• Kalay N , CaglayanO, AkkayaHet al. The deletion polymorphism of the angiotensin-converting enzyme gene is associated with acute aortic dissection. Tohoku J. Exp. Med. 219(1), 33–37 (2009).
   PubMed Web of Science ®Google Scholar
• Jing QM , WangXZ, MaYYet al. Angiotensin-converting enzyme I/D polymorphism and the risk of thoracic aortic dissection in Chinese Han population. Mol. Biol. Rep. 40(2), 1249–1254 (2013).
   PubMed Web of Science ®Google Scholar
• Danyi P , ElefteriadesJA, JovinIS. Medical therapy of thoracic aortic aneurysms. Trends Cardiovasc. Med.22(7), 180–184 (2012).
   PubMed Web of Science ®Google Scholar
• Wooderchak-Donahue WL , O‘FallonB, FurtadoLVet al. A direct comparison of next generation sequencing enrichment methods using an aortopathy gene panel- clinical diagnostics perspective. BMC Med. Genomics 5, 50 (2012).
   PubMed Web of Science ®Google Scholar
• Rehm HL . Disease-targeted sequencing: a cornerstone in the clinic. Nat. Rev. Genet.14(4), 295–300 (2013).
   PubMed Web of Science ®Google Scholar
• Baetens M , Van LaerL, De LeeneerKet al. Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys–Dietz syndromes. Hum. Mutat. 32(9), 1053–1062 (2011).
   PubMed Web of Science ®Google Scholar
• Sakai H , SuzukiS, MizuguchiTet al. Rapid detection of gene mutations responsible for non-syndromic aortic aneurysm and dissection using two different methods: resequencing microarray technology and next-generation sequencing. Hum. Genet. 131(4), 591–599 (2012).
   PubMed Web of Science ®Google Scholar
• Jondeau G , MichelJB, BoileauC. The translational science of Marfan syndrome. Heart97(15), 1206–1214 (2011).
   PubMed Web of Science ®Google Scholar
• Regalado E , MedrekS, Tran-FaduluVet al. Autosomal dominant inheritance of a predisposition to thoracic aortic aneurysms and dissections and intracranial saccular aneurysms. Am. J. Med. Genet. A 155A(9), 2125–2130 (2011).
   PubMed Web of Science ®Google Scholar
• Bamshad MJ , NgSB, BighamAWet al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12(11), 745–755 (2011).
   PubMed Web of Science ®Google Scholar
• Gilissen C , HoischenA, BrunnerHG, VeltmanJA. Disease gene identification strategies for exome sequencing. Eur. J. Hum. Genet.20(5), 490–497 (2012).
   PubMed Web of Science ®Google Scholar
• Hatzaras IS , BibleJE, KoulliasGJ, TranquilliM, SinghM, ElefteriadesJA. Role of exertion or emotion as inciting events for acute aortic dissection. Am. J. Coll. Cardiol.100(9), 1470–1472 (2007).
   Google Scholar
• Brunner HG . The variability of genetic disease. N. Engl. J. Med.367(14), 1350–1352 (2012).
   PubMed Web of Science ®Google Scholar
• Eagle KA ; GenTAC Consortium. Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC). Am. Heart J.157(2), 319–326 (2009).
   PubMed Web of Science ®Google Scholar
• Kroner BL , TolunayHE, BassonCTet al. The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): results from Phase I and scientific opportunities in Phase II. Am. Heart J. 162(4), 627-U677 (2011).
   PubMed Web of Science ®Google Scholar
• Kuang SQ , GuoDC, PrakashSKet al. Recurrent chromosome 16p13.1 duplications are a risk factor for aortic dissections. PLoS Genet. 7(6), e1002118 (2011).
   PubMed Web of Science ®Google Scholar
• Habashi JP , JudgeDP, HolmTMet al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312(5770), 117–121 (2006).
   PubMed Web of Science ®Google Scholar
• Gambarin FI , FavalliV, SerioAet al. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations. J. Cardiovasc. Med. 10(4), 354–362 (2009).
   Google Scholar
• Lacro RV , DietzHC, WruckLMet al. Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. Am. Heart J. 154(4), 624–631 (2007).
   PubMed Web of Science ®Google Scholar
• Radonic T , de WitteP, BaarsMJet al. Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial. Trials 11, 3 (2010).
   PubMed Web of Science ®Google Scholar
• Habashi JP , DoyleJJ, HolmTMet al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332(6027), 361–365 (2011).
   PubMed Web of Science ®Google Scholar
• McBride KL , GargV. Impact of Mendelian inheritance in cardiovascular disease. Ann. N.Y. Acad. Sci.1214, 122–137 (2010).
   PubMed Web of Science ®Google Scholar
• Pearson GD , DevereuxR, LoeysBet al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation 118(7), 785–791 (2008).
   PubMed Web of Science ®Google Scholar
• Castellano JM , KovacicJC, SanzJ, FusterV. Are we ignoring the dilated thoracic aorta?Ann. N.Y. Acad. Sci.1254, 164–174 (2012).
   PubMed Web of Science ®Google Scholar
• Iba Y , MinatoyaK, MatsudaHet al. Surgical experience with aggressive aortic pathologic process in Loeys–Dietz syndrome. Ann. Thorac. Surg. 94(5), 1413–1417 (2012).
   PubMed Web of Science ®Google Scholar
• Lehner B . Genotype to phenotype: lessons from model organisms for human genetics. Nat. Rev. Genet.14(3), 168–178 (2013).
   PubMed Web of Science ®Google Scholar
• Ho CY , MacraeCA. Defining the pathogenicity of DNA sequence variation. Circ. Cardiovasc. Genet.2(2), 95–97 (2009).
   PubMedGoogle Scholar
• Lupski JR . Digenic inheritance and Mendelian disease. Nat. Genet.44(12), 1291–1292 (2012).
   PubMed Web of Science ®Google Scholar
• Kelly M , SemsarianC. Multiple mutations in genetic cardiovascular disease a marker of disease severity?Circ. Cardiovasc. Genet.2(2), 182–190 (2009).
   PubMedGoogle Scholar
• Doyle JJ , GerberEE, DietzHC. Matrix-dependent perturbation of TGFβ signaling and disease. FEBS Lett.586(14), 2003–2015 (2012).
   PubMed Web of Science ®Google Scholar
• Renard M , HolmT, VeithRet al. Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. Eur. J. Hum. Genet. 18(8), 895–901 (2010).
   PubMed Web of Science ®Google Scholar
• Walz G . Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med.363(9), 830–840 (2010).
   PubMed Web of Science ®Google Scholar

▪ Website

• Arslan-Kirchner M, Arbustini E, Boileau C et al. Clinical utility gene card for: Marfan syndrome type 1 and related phenotypes [FBN1]. www.ncbi.nlm.nih.gov/pmc/articles/PMC2987429/pdf/ejhg201042a.pdf
   Google Scholar